K Arulanantham, M Genel. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralCentral Nervous System Diseases/chemically inducedChildHumansMalePharmaceutical VehiclesPropylene Glycols/administration & dosagePropylene Glycols/adverse effectsSeizures/chemically induced
Substances: See more » Pharmaceutical VehiclesPropylene Glycols
Year: 1978 PMID: 690781 DOI: 10.1016/s0022-3476(78)81183-4
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406